Woman, 2 others sent to prosecutors for illegally selling diabetes drug Mounjaro
En resumen
- Osaka Prefectural Police have referred a 35-year-old company employee and two others to prosecutors on suspicion of violating the Pharmaceuticals and Medical Devices Act by illegally selling and storing the diabetes drug Mounjaro without a license.
- The drug, known for its appetite-suppressing effects and marketed as a "slimming drug" on social media, has seen widespread use for diet purposes.
Resumen generado por IA
Por qué importa
The diabetes treatment drug Mounjaro is being sold and stored without a license in Osaka. Mounjaro is a subcutaneous injection that suppresses appetite and is also known as a "slimming drug" on social media, particularly among women, for its weight loss effects. However, it can cause digestive side effects such as nausea and vomiting.
糖尿病治療薬「マンジャロ」を無許可で販売、保管したとして、大阪府警生活環境課は2日、医薬品医療機器法違反の疑いで、大阪府枚方市の会社員の女(35)ら3人を書類送検した。いずれも容疑を認めている。
米イーライリリー、時価総額1兆ドル突破 製薬業界初、肥満症薬が好調
マンジャロは皮下注射型の薬で、食欲を抑える効果がある一方、吐き気や嘔吐(おうと)など消化器系の副作用が生じる場合がある。女性を中心にダイエット目的での使用が広まり、SNSでは「痩せ薬」とも呼ばれている。
女の送検容疑は昨年12月、SNS上で知り合った女性2人に、病院で処方されたマンジャロを無許可で販売した疑い。他の2人は、SNSなどで入手したマンジャロを販売目的で、自宅に保管した疑いがある。
Preguntas abiertas
- What is the total quantity of Mounjaro illegally sold or stored?
- What is the source of the illegally obtained Mounjaro?
- Are there other individuals or groups involved in this illegal operation?
- What is the extent of the side effects experienced by users of the illegally sold Mounjaro?




